The Latest
-
Oppenheimer: 3 “Strong Buy” Stocks With Over 30% Upside Ahead
-
Biogen: Approval Prospects for Aducanumab Amount to a Flip of a Coin, Says J.P. Morgan
-
Work remotely from Barbados for a year
-
Hotel industry is not expected to recover until 2023: AHLA CEO